Neisseria meningitidis serogroups A and C polysaccharide capsule — Drug Target

All drugs that target Neisseria meningitidis serogroups A and C polysaccharide capsule — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Polysaccharide conjugate vaccine · Polysaccharide vaccine

Marketed (1)

• A+C Vaccine · Jiangsu Province Centers for Disease Control and Prevention · Polysaccharide conjugate vaccine · Immunology / Infectious Disease
  A+C Vaccine is a combined meningococcal vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroups A and C.

Phase 3 pipeline (1)

• A+C Meningococcal Polysaccharide Vaccine · Hualan Biological Engineering, Inc. · Polysaccharide vaccine · Immunology / Infectious Disease
  This vaccine stimulates the immune system to produce antibodies against meningococcal serogroups A and C polysaccharide antigens, providing protection against meningococcal disease.